期刊文献+

CFP10-ESAT-6-MPB64在杆状病毒系统中的表达纯化及免疫原性鉴定 被引量:2

Expression,Purification and Immunogenicity Analysis of Recombinant CFP10-ESAT-6-MPB64 Using the Baculovirus Expression System
原文传递
导出
摘要 目的:在杆状病毒昆虫细胞表达系统 ( baculovirus expression vector system,BEVS)中表达结核分枝杆菌蛋白 CFP10-ESAT-6-MPB64,并鉴定其免疫原性。方法:目的基因CFP10-ESAT-6-MPB64连接到pFastBac转移载体并转化DH10Bac感受态,通过Tn7转座片段将目的基因转座到Bacmid中,得到Bacmid-CFP10-ESAT-6-MPB64穿梭载体,脂质体包被后转染Spodoptera frugiperda(Sf9)细胞收获病毒,病毒转染细胞后收集上清通过Co亲和层析纯化得到目的蛋白。纯化的蛋白免疫Balb/c小鼠并检测血清中特异性抗体滴度及PPD抗体,ELISA检测CFP10-ESAT-6-MPB64蛋白刺激脾脏细胞产生IFN-γ的浓度,MTT法检测目的蛋白对免疫后小鼠脾脏细胞的增殖作用。结果:CFP10-ESAT-6-MPB64在昆虫细胞中成功表达,纯化后蛋白纯度达90%以上,蛋白产量为42mg/L,纯化蛋白能有效刺激Balb/c小鼠产生抗体,提高小鼠脾脏细胞培养基中IFN-γ的含量,目的蛋白在1-50g/ml之间对脾脏细胞有明显的促增殖作用。 Objective: To express Mycobacterium tuberculosis protein CFP10-ESAT-6-MPB64 in baculovirus insect cell expression system, and identify its immunogenicity. Methods: The target gene CFP10-ESAT-6-MPB64 was connected to pFastBac vector, then the pFastBac-CFP10-ESAT-6-MPB64 plasmid which was harvested would transformed to DH10Bac competent, and the target gene was transposition into Bacmid by Tn7 transposase fragment, therefore Bacmid-CFP10-ESAT-6-MPB64 Shuttle vector was obtained. The shuttle vector was packaged by liposomes and transfected Sf9 cells to harvest Pl-generation virus, then high titers of P4 generation virus was harvested by repeat transfected Sf9 cells three times. The target protein CFP10-ESAT-6-MPB64 was purified from the supematant by Co affine chromatography, which were used to immunize Balb/c mice. Antibody changes in serum would be detected, and the proliferation of immunized mice spleen cells would be detected by MTF, detected the IFN-γ secretion by CFP10-ESAT-6-MPB64 stimulated spleen cells by ELISA method. Result: CFP10-ESAT-6-MPB64 successfully expressed in insect cells. The purity of target protein is over 90% and yield up to 42mg/L after purification. Purified protein can effectively stimulate Balb/c mice to produce antibodies, increase the content of IFN-7 medium in mice spleen cells, and significantly promoting proliferation in spleen cells between 1 - 50μg/ml. Conclusion: CFP10-ESAT-6-MPB64 which has immunogenicity was successfully expressed in baculovirus insect cell expression system, that open a new avenue for tuberculosis vaccine production.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2014年第6期23-30,共8页 China Biotechnology
基金 国家"863"计划(SQ2011AA100606) 浙江省自然科学基金(LY13H300006) 2012年省级重点科技创新团队项目(2012R10042-10) 2012年吉林省高层次创新创业引进人才项目资助项目
关键词 BEVS SF9细胞 结核分枝杆菌 BEVS Sf9 Mycobacterium tuberculosis
  • 相关文献

参考文献18

  • 1http://www, who. int/tb/publieations/global_ report/gtbrl2 _ executivesummary, pdf [ accessed on 30.04.13 ].
  • 2Wright A, Zignol M, Deun A V. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet. 2009. 373: 1861-1873.
  • 3Shah N S, Wright A, Bai G H. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis, 2007, 13 : 380-387.
  • 4Gandhi N R, Moll A, Sturm A W. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet, 2006,368 : 1575-1580.
  • 5Harries A D, Zachariah R, Corbett E L. The HIV-associated tuberculosis epidemic-when will we act. Lancet, 2010,375:906- 1919.
  • 6Ghebreyesus T A, Kazatchkine M, Sidib6 M. Tuberculosis and HIV : time for an intensified response. Lancet, 2010,375 : 1757- 1758.
  • 7Fine P E. Variation in protection by BCG : implications of and for heterologous immunity. Lancet, 1995,346 : 1339-1345.
  • 8Skeiky Y A, Sadoff J C. Advances in tuberculosis vaccine strategies. Nat Rev Microbiol, 2006,4:469476.
  • 9Mahairas G G, Sabo P J, Hickey M J. Molecular analysis of genetic differences between Mycobacterium boris BCG and virulent M. bov/s. Bacteriology, 1996,178:1274-1282.
  • 10Skjot R L, Oettinger T, Rosenkrands I, Comparative evaluation of Low-molecularmass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T cell antigens. Infect Immun, 2000,68:214-220.

同被引文献44

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部